[Treatment effect of breast cancer and prostate cancer on bone]

Med Clin (Barc). 2013 Feb 16;140(4):164-8. doi: 10.1016/j.medcli.2012.05.025. Epub 2012 Jul 28.
[Article in Spanish]

Abstract

Aromatase inhibitors are used in the treatment of breast cancer and androgen deprivation therapy is used in prostate cancer. Both of them induce bone loss and increase fracture incidence. Early detection is important for patients with increased risk of osteoporotic fractures. In this article we review the available treatments and their indication to prevent the onset of osteoporosis and osteoporotic fractures in this patient group.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Algorithms
  • Androgen Antagonists / adverse effects*
  • Androgen Antagonists / therapeutic use
  • Aromatase Inhibitors / adverse effects*
  • Aromatase Inhibitors / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Female
  • Humans
  • Male
  • Osteoporosis / chemically induced*
  • Osteoporotic Fractures / chemically induced*
  • Prostatic Neoplasms / drug therapy*

Substances

  • Androgen Antagonists
  • Aromatase Inhibitors